Back­ing Bio­gen, 75+ House Re­pub­li­cans call on CMS to aban­don its de­ci­sion to lim­it amy­loid-tar­get­ed Alzheimer's drugs to tri­als

Top Re­pub­li­cans are call­ing on HHS “to aban­don and re-pro­pose” a draft na­tion­al cov­er­age de­ci­sion from CMS on an­ti-amy­loid Alzheimer’s drugs, which seeks to re­strict …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER